BRIEF

on SARTORIUS STED BIO (EPA:DIM)

Sartorius Stedim Biotech Boosts Capacity in France for Bioprocess Solutions

Stock price chart of SARTORIUS STED BIO (EPA:DIM) showing fluctuations.

Sartorius Stedim Biotech has completed a significant expansion at its Aubagne, France headquarters. The project established nearly 9,000 square meters of cleanroom space dedicated to single-use bags utilized in biopharmaceutical manufacturing. This initiative responds to increased demand for bioprocessing solutions. The company's newly automated logistics and manufacturing systems enhance productivity and delivery efficiency.

The expansion includes a 12,000-square-meter high-bay warehouse and a cross-functional lab space. These facilities will support product development, customer demos, and training. The site is designed with environmental sustainability in mind, earning certifications such as ISCC Plus and ISO 14001.

This project underscores Sartorius Stedim Biotech's commitment to innovation and sustainability, strengthening its position in the biopharmaceutical industry. Since 2021, the company has significantly invested in its French operations, employing around 1,400 staff across various sites. The endeavor aims to facilitate the rapid and sustainable manufacture of biotech medications.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all SARTORIUS STED BIO news